Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-19

Clinical Trial Update: Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP) [NA]

View source ↗

Summary

A completed clinical trial studying reduction of right ventricular pacing using the VIP feature in patients with bradycardia; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Bradycardia | NA | Status: COMPLETED | Results posted: 2021-07-19